PFE:NYE-Pfizer Inc.

EQUITY | Drug Manufacturers | New York Stock Exchange

Last Closing Price

USD 36.60

Change

+0.06 (+0.16)%

Market Cap

USD 218.16B

Volume

0.03B

Yahoo Analyst Target

USD 38.29 (4.62%)

STA Analyst Target

USD 37.78 (3.23%)
Yahoo Analyst Rating

Verdict

STA Analyst Rating

Verdict

STA Verdict

Verdict

About

Pfizer Inc is a research-based biopharmaceutical company. The Company's portfolio includes medicines, vaccines and medical devices, as well as many of the consumer healthcare products.

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2018-01-16 )

Largest Industry Peers for Drug Manufacturers

Symbol Name Price(Change) Market Cap
JNJ Johnson & Johnson

+1.10 (+0.75%)

USD 394.54B
NVS Novartis AG

+0.08 (+0.09%)

USD 203.20B
MRK Merck & Company Inc. (new)

+3.41 (+5.81%)

USD 169.11B
ABBV AbbVie Inc.

+2.15 (+2.14%)

USD 163.62B
SNY Sanofi American Depositary Sha..

+0.13 (+0.29%)

USD 113.03B
ABT Abbott Laboratories

-0.40 (-0.68%)

USD 101.72B
BMY Bristol-Myers Squibb Company

-2.89 (-4.60%)

USD 98.07B
GSK GlaxoSmithKline PLC

+0.42 (+1.12%)

USD 94.00B
LLY Eli Lilly and Company

-1.69 (-1.94%)

USD 93.91B
AZN Astrazeneca PLC

-0.66 (-1.85%)

USD 88.61B

ETFs Containing PFE

IHE iShares U.S. Pharmaceutic.. 8.45 % 0.44 %

-0.97 (0.58%)

USD 0.57B
FTXH First Trust Nasdaq Pharma.. 7.74 % 0.60 %

-0.24 (0.58%)

USD 2.22M
XLV SPDR Select Sector Fund -.. 6.75 % 0.14 %

+0.43 (+0.58%)

USD 17.56B
IYH iShares U.S. Healthcare 6.52 % 0.44 %

+0.62 (+0.58%)

USD 2.04B
FHLC Fidelity MSCI Health Care.. 5.89 % 0.08 %

+0.09 (+0.58%)

USD 0.97B
VHT Vanguard Health Care 5.82 % 0.10 %

+0.25 (+0.58%)

USD 7.51B
SHE SPDR Series Trust SSGA Ge.. 5.81 % 0.20 %

-0.25 (0.58%)

USD 0.38B
JHMH John Hancock Multifactor .. 5.25 % 0.50 %

+0.18 (+0.58%)

USD 0.04B
RXL ProShares Ultra Health Ca.. 5.21 % 0.95 %

+0.76 (+0.58%)

USD 0.12B
FDL First Trust Morningstar 5.20 % 0.45 %

-0.14 (0.58%)

USD 1.74B
HDV iShares Core High Dividen.. 5.20 % 0.10 %

-0.04 (0.58%)

USD 6.77B
XHD:CA iShares U.S. High Dividen.. 5.12 % 0.33 %

-0.01 (0.58%)

CAD 0.24B
XHU:CA iShares U.S. High Dividen.. 5.11 % 0.34 %

+0.08 (+0.58%)

CAD 0.03B
HHL:CA Healthcare Leaders Income.. 5.10 % 1.37 %

-0.04 (0.58%)

CAD 0.26B
PJP PowerShares Dynamic Pharm.. 4.92 % 0.56 %

-0.32 (0.58%)

USD 0.66B
XPH SPDR S&P Pharmaceuticals 4.83 % 0.35 %

-0.45 (0.58%)

USD 0.41B
PPH VanEck Vectors Pharmaceut.. 4.81 % 0.35 %

-0.10 (0.58%)

USD 0.30B
DJD Guggenheim Dow Jones Indu.. 4.65 % 0.30 %

-0.05 (0.58%)

USD 0.01B
IXJ iShares Global Healthcare 4.61 % 0.48 %

+0.06 (+0.58%)

USD 1.70B
SCHD Schwab US Dividend Equity 4.34 % 0.07 %

-0.09 (0.58%)

USD 7.44B
ZWH:CA BMO US High Dividend Cove.. 3.86 % 0.71 %

-0.14 (0.58%)

CAD 0.69B
ZWH.U:CA BMO US High Dividend Cove.. 3.86 % 0.72 %

-0.08 (0.58%)

CAD 0.06B
VLUE iShares Edge MSCI USA Val.. 3.39 % 0.15 %

N/A

USD 2.42B
ZVU:CA BMO MSCI USA Value Index .. 3.36 % 0.00 %

-0.13 (0.58%)

CAD 8.87M
JKF iShares Morningstar Large.. 3.33 % 0.25 %

+0.01 (+0.58%)

USD 0.42B
RNDV First Trust US Equity Div.. 3.23 % 0.00 %

+0.13 (+0.58%)

USD 0.01B
QDYN FlexShares Quality Dynami.. 3.23 % 0.37 %

N/A

USD 0.06B
QDEF FlexShares Quality Divide.. 3.21 % 0.37 %

-0.07 (0.58%)

USD 0.33B
XDU:CA iShares Core MSCI US Qual.. 3.15 % 0.00 %

-0.07 (0.58%)

CAD 0.01B
QDF FlexShares Quality Divide.. 3.01 % 0.37 %

-0.14 (0.58%)

USD 2.01B
DHS WisdomTree U.S. High Divi.. 2.98 % 0.38 %

-0.14 (0.58%)

USD 1.23B
HID:CA WisdomTree U.S. High Divi.. 2.91 % 0.48 %

+0.13 (+0.58%)

CAD 0.01B
OUSA O'Shares FTSE U.S. Qualit.. 2.90 % 0.48 %

-0.03 (0.58%)

USD 0.58B
DGRO iShares Core Dividend Gro.. 2.88 % 0.09 %

-0.05 (0.58%)

USD 2.84B
SHU:CA Sphere FTSE US Sustainabl.. 2.83 % 0.70 %

N/A

CAD 3.41M
WEXP WisdomTree U.S. Export an.. 2.68 % 0.33 %

N/A

USD 0.82M
RFDA RiverFront Dynamic US Div.. 2.46 % 0.52 %

-0.19 (0.58%)

USD 0.07B
XDG:CA iShares Core MSCI Global .. 2.45 % 0.00 %

-0.05 (0.58%)

CAD 0.02B
VYM Vanguard High Dividend Yi.. 2.11 % 0.08 %

-0.25 (0.58%)

USD 21.76B
LVL Guggenheim Global Dividen.. 1.95 % 0.64 %

+0.02 (+0.58%)

USD 0.06B
DLN WisdomTree U.S. LargeCap .. 1.93 % 0.28 %

-0.15 (0.58%)

USD 2.10B
PILL Direxion Daily Pharmaceut.. 1.78 % 0.00 %

-0.33 (0.58%)

USD 3.19M
DEW WisdomTree Global High Di.. 1.77 % 0.58 %

+0.03 (+0.58%)

USD 0.11B
VONV Vanguard Russell 1000 Val.. 1.71 % 0.12 %

-0.42 (0.58%)

USD 1.37B
SCHV Schwab U.S. Large-Cap Val.. 1.67 % 0.05 %

-0.20 (0.58%)

USD 4.25B
DTD WisdomTree U.S. Total Div.. 1.65 % 0.28 %

-0.23 (0.58%)

USD 0.65B
FVAL Fidelity Value Factor 1.62 % 0.29 %

-0.15 (0.58%)

USD 0.07B
JQUA JPMorgan U.S. Quality Fac.. 1.62 % 0.00 %

N/A

N/A
FQAL Fidelity Quality Factor 1.62 % 0.29 %

-0.18 (0.58%)

USD 0.05B
FDLO Fidelity Low Volatility F.. 1.60 % 0.29 %

N/A

USD 0.05B
JVAL JPMorgan U.S. Value Facto.. 1.59 % 0.00 %

N/A

N/A
CDL Compass EMP US Large Cap .. 1.53 % 0.35 %

-0.16 (0.58%)

N/A
CDC Compass EMP US EQIncome 1.. 1.52 % 0.35 %

-0.13 (0.58%)

USD 0.03B
ZDY:CA BMO US Dividend ETF 1.43 % 0.33 %

-0.38 (0.58%)

CAD 1.40B
FNDX Schwab Fundamental U.S. L.. 1.34 % 0.32 %

-0.22 (0.58%)

USD 3.98B
XMU:CA iShares Edge MSCI Min Vol.. 1.33 % 0.34 %

-0.03 (0.58%)

CAD 0.16B
USMV iShares Edge MSCI Min Vol.. 1.33 % 0.15 %

N/A

USD 13.46B
FNDB Schwab Fundamental U.S. B.. 1.23 % 0.32 %

-0.15 (0.58%)

USD 0.31B
DFU:CA Desjardins USA Multifacto.. 0.79 % 0.00 %

N/A

CAD 5.22M

Market Performance

  Market Performance vs.
Industry/Classification (Drug Manufacturers)
Market Performance vs. Exchange (New York Stock Exchange)
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 1.05% 22% F 46% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 1.05% 22% F 45% F
Trailing 12 Months  
Capital Gain 12.55% 52% F 59% F
Dividend Return 3.94% 82% B- 57% F
Total Return 16.48% 52% F 60% D-
Trailing 5 Years  
Capital Gain 37.54% 44% F 62% D-
Dividend Return 21.04% 73% C 62% D-
Total Return 58.59% 44% F 62% D-
Average Annual (5 Year Horizon)  
Capital Gain 4.46% 48% F 57% F
Dividend Return 8.03% 48% F 56% F
Total Return 3.58% 76% C 61% D-
Risk Return Profile  
Volatility (Standard Deviation) 8.53% 100% A+ 78% C+
Risk Adjusted Return 94.08% 83% B 75% C
Market Capitalization 188.79B 95% A 100% A+

Key Financial Ratios

  Ratio vs. Industry/Classification
(Drug Manufacturers)
Ratio vs. Market
(New York Stock Exchange)
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
Market Value  
Price / Earning Ratio 392.90 57% F 38% F
Price/Book Ratio 3.73 39% F 26% F
Price / Cash Flow Ratio 3.57 65% D 38% F
Price/Free Cash Flow Ratio 16.56 70% C- 42% F
Management Effectiveness  
Return on Equity 16.55% 65% D 78% C+
Return on Invested Capital 15.06% 65% D 76% C
Return on Assets 5.76% 70% C- 75% C
Debt to Equity Ratio 73.25% 55% F 52% F

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
High market capitalization

This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.

Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

Low volatility

The stock’s annual returns have been stable and consistent compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile. Although stability is good, also keep in mind it can limit returns.

Superior total returns

The stock has outperformed its sector peers on average annual total returns basis in the past 5 years (for a hold period of at least 12 months) and is in the top quartile.

Positive cash flow

The company had positive total cash flow in the most recent four quarters.

Positive free cash flow

The company had positive total free cash flow in the most recent four quarters.

Superior Dividend Growth

This stock has shown top quartile dividend growth in the previous 5 years compared to its sector

What to not like:
Below median dividend returns

The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.

Overpriced compared to book value

The stock is trading high compared to its peers median on a price to book value basis.

Overpriced on free cash flow basis

The stock is trading high compared to its peers on a price to free cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.

Low Revenue Growth

This stock has shown below median revenue growth in the previous 5 years compared to its sector